Skip to content
Menu

Talphera, Inc. TLPH

Full chart Compare
Set alert

Price alert · TLPH

All alert types
0.74 USD -0.06 (-7.63%)

Regular-session close

0.74 0.00 0.00%

After hours · Nov 19, 4:00 PM ET

0.7302 Day range 0.8032
0.69 52-week range 1.57
YTD
-35.18%
1 year
-44.02%

5D -0.2492 (-23.73%)

0.80000.90001.00001.1000WedThuFriMonTue0.8008
Market cap
38.40M
Revenue (ttm)
398.00K
EPS (ttm)
-0.21
Shares out
17.03M
Forward P/E
-0.63
YTD return
-35.18%
1-year return
-44.02%
50-day average
0.8056
Volume
191.25K
Avg volume
140.94K
Open
0.79
Previous close
0.80
Day's range
0.7302 – 0.8032
52-week range
0.69 – 1.57
Beta
0.30
Price target
4.17 (+463.8%)

Key statistics

200-day average
0.93205
Enterprise value
3.76M
Price / sales
26.23
Price / book
0.74
Free cash flow
-10.63M
Total cash
14.02M
Total debt
6.53M
Return on equity
-118.40%
Short % of float
0.67%

Fundamental scorecard

4 of 25 checks passed on TLPH’s reported financials

ValueGrowthProfitabilityHealthDividend

4of 25 checks passed

  • Value 0 of 5
  • Growth 1 of 5
  • Profitability 0 of 5
  • Financial health 3 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
TLPH Revenue — quarterly 0
TLPH Net income — quarterly -4.02M
TLPH EPS — quarterly -0.05

Earnings

TLPH recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 13, 2024Sep 1, 2024-0.20-0.13+0.07+35.00%
Aug 14, 2024Jun 1, 2024-0.22-0.15+0.07+31.82%
May 14, 2024Mar 1, 2024-0.28-0.16+0.12+42.86%
Mar 6, 2024Dec 1, 2023-0.24-0.25-0.01-4.17%

Upgrades / downgrades

TLPH analyst upgrades and downgrades
DateFirmActionFromTo
Aug 16, 2024HC Wainwright & Co.reitBuyBuy
May 15, 2024HC Wainwright & Co.reitBuyBuy
May 6, 2024Maxim Groupinit—Buy
Mar 7, 2024HC Wainwright & Co.reitBuyBuy
Jan 22, 2024HC Wainwright & Co.mainBuyBuy
Dec 7, 2023HC Wainwright & Co.reitBuyBuy

About Talphera, Inc.

Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is headquartered in San Mateo, California.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
United States
Website
talphera.com

News

Your note

Sign in to keep a note on TLPH — it syncs with the Stock Master app.

Insider holders

TLPH insider holders
InsiderRelationLatest transactionDateShares held
ADAMS ADRIANDirectorStock Award(Grant)Jun 23, 202413,342
ANGOTTI VINCENT JChief Executive OfficerPurchaseDec 4, 2024208,066
ASADORIAN RAFFIChief Financial OfficerSaleDec 1, 202437,578
BOZILENKO MARINADirectorStock Award(Grant)Jun 23, 20244,780
BROADFOOT JILL MARIEDirectorStock Award(Grant)Jun 23, 20244,280
DASU BADRI NOfficerStock Award(Grant)Feb 13, 202431,820

Institution ownership

TLPH institution ownership
Holder% heldSharesValueReported
Nantahala Capital Management, LLC11.70%1,992,5191.22MSep 29, 2024
Rosalind Advisors, Inc.4.46%758,966465.25KSep 29, 2024
Rock Springs Capital Management, LP1.86%316,460193.99KSep 29, 2024
MAI Capital Management1.66%282,342173.07KSep 29, 2024
Vanguard Group Inc1.42%240,970147.71KSep 29, 2024
Geode Capital Management, LLC0.91%155,49595.32KSep 29, 2024

Fund ownership

TLPH fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund0.94%159,61297.84KSep 29, 2024
Fidelity Extended Market Index Fund0.57%97,09259.52KOct 30, 2024
Vanguard Extended Market Index Fund0.48%81,35849.87KSep 29, 2024
Fidelity Series Total Market Index Fund0.13%22,88914.03KOct 30, 2024
Fidelity NASDAQ Composite Index Fund0.10%16,36610.03KOct 30, 2024
Fidelity Total Market Index Fund0.09%15,7649.66KOct 30, 2024